ACYLANID Drug Patent Profile
✉ Email this page to a colleague
When do Acylanid patents expire, and what generic alternatives are available?
Acylanid is a drug marketed by Novartis and is included in one NDA.
The generic ingredient in ACYLANID is acetyldigitoxin. Additional details are available on the acetyldigitoxin profile page.
Summary for ACYLANID
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 30 |
Patent Applications: | 349 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ACYLANID at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for ACYLANID
US Patents and Regulatory Information for ACYLANID
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novartis | ACYLANID | acetyldigitoxin | TABLET;ORAL | 009436-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |